News Feed

Researchers use gene therapy to restore hearing and balance in mouse model of Usher syndrome

Hearing loss, sometimes associated with other disorders such as balance defects, is the most common sensory deficit, affecting more than 280 million people worldwide, according to WHO. In France, one child in 700 is born with severe or profound hearing loss, and one in every 1,000 will lose their sense of hearing before adulthood.

MED-EL introduces world’s first cochlear implant powered by wireless charging

MED-EL, a leading provider of hearing implant systems, has today launched the world’s first cochlear implant audio processor to feature wireless charging at the 61st Austrian National Otorhinolaryngology, Head and Neck Surgery Conference.

Scientists take important step toward gene therapy for deaf patients

Scientists at Oregon State University have taken an important step toward gene therapy for deaf patients by developing a way to better study a large protein essential for hearing and finding a truncated version of it.

Study highlights complexity of childhood cancer survivors’ medical needs

Survivors of childhood cancer may experience, on average, nearly twice as many chronic health condition by the age of 45, compared to the general population, according to a new study led by St Jude Children’s Research Hospital (USA) and published in The Lancet.

IUPUI cell biologist receives $1.9 million grant to tackle age-related hearing loss

Cell biologist Benjamin J. Perrin of the School of Science at Indiana University-Purdue University Indianapolis is advancing knowledge of age-related hearing loss with the goal of informing possible therapeutic cell-regeneration approaches to the often-debilitating problem.

Research finds serious visual impairment among children with congenital Zika syndrome

Although one of the most serious consequences of the Zika virus (ZIKV) in infants is microcephaly, there is a broad collection of anomalies now known as congenital Zika syndrome (CZS). Some of the most serious are ophthalmologic, including macular scarring, retinal defects, low visual acuity, strabismus, and nystagmus.

Insmed reports top-line data from Phase 3 study of new treatment in patients with NTM lung disease

Insmed Incorporated, a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced top-line data from its Phase 3 CONVERT study.

Salk professor awarded $950,000 NSF grant to explore how the brain processes complex sounds

Salk Associate Professor Tatyana Sharpee has been awarded a grant of approximately $950,000 over 4 years by the National Science Foundation to study how the brain processes complex sounds. This grant is part of a multi-national project together with groups in France and Israel.

Mild pain killer blocks action of key protein required for hearing

A Rice University study has found that the aspirin-like drug diflunisal blocks the action of prestin, a key protein that is required for hearing.

SLU-led project receives NIH funding for clinical trial on potential treatment for MDR-TB

Saint Louis University is leading a multi-national clinical trial of what could become a regimen for drug resistant tuberculosis (TB) that does not require injectable medications. The project is funded by a $6.4 million task order from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.